Cite
HARVARD Citation
Nitta, K. et al. (2016). Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen. BioMed research international. p. . [Online].